Singapore, 20 June 2025 – The National Heart Centre Singapore (NHCS) and Mayo Clinic have collaborated under a Memorandum of Understanding (MOU) to accelerate cardiovascular innovation and research, and to foster knowledge for future cardiovascular care worldwide. This is a result of a two-day scientific meeting between the two organisations, which is supported by the Tanoto Foundation - an independent family foundation that catalyses system changes in education, healthcare and leadership development.
Advancing Cardiovascular Care, Research and Knowledge Exchange
The collaboration brings together Mayo Clinic's expertise with NHCS's deep understanding of Asian cardiovascular health. By establishing a collaborative platform for knowledge exchange, the joint effort will hope to create new opportunities for breakthrough research and accelerate the development of new treatment paradigms that will benefit Asian and global patient populations.
Several high priorities areas were identified as initial steps for the collaboration:
Future Plans
Looking ahead, NHCS and Mayo Clinic envision co-developing shared intellectual property, clinical protocols and guidelines that serve Western and Asian populations. This strategic alignment will accelerate innovation in cardiac care and foster cross-exchange of expertise to empower healthcare professionals through training and education to impact cardiovascular care and outcomes on a global scale.
“This collaboration brings together two leading academic cardiovascular medical centres with similar values and strong commitment to patient care to co-create better outcomes for our patients," said Professor Yeo Khung Keong, Chief Executive Officer, NHCS. "Cardiovascular disease remains a leading health concern in Asia, making it crucial to address its challenges. With this collaboration, we aim to accelerate the development of solutions tailored to our population's specific needs while building capabilities that will benefit future generations of healthcare professionals.”
“The Mayo Clinic Cardiovascular Research Centre is looking forward to the upcoming collaboration and shares the mutual vision of improving cardiovascular health worldwide,” said Profe ssor Amir Lerman, Director of the Mayo Cardiovascular Research Centre and Barbara Woodward Lips Professor of Medicine at Mayo Clinic .
“We look forward to collaborating to enhance the insights and tools that will improve global cardiovascular health through screening, detection, therapy, and understanding of disease mechanisms,” said Profe ssor Paul Friedman, Chair, Cardiovascular Medicine Honouring Robert L. Frye, M.D. and the Betty Knight Scripps - George M. Gura, Jr., M.D., Professor of Medicine at Mayo Clinic .
References:
Chinese Glossary
National Heart Centre Singapore (NHCS)
新加坡国家心脏中心
Professor Yeo Khung Keong
Chief Executive Officer, NHCS
杨孔健教授
总裁, 新加坡国家心脏中心
Mayo Clinic
妙佑医疗国际
Media Contact
Ms Belinda Lim
National Heart Centre Singapore
Mobile: (65) 9689 7453
Email: belinda.lim.s.m@nhcs.com.sg
Ms Amy Weng
Mobile: (65) 9740 9926
Email: amy.weng.xueqi@nhcs.com.sg
About the National Heart Centre Singapore
The National Heart Centre Singapore (NHCS) is a leading national and regional referral centre for cardiovascular diseases, offering 185 beds and a comprehensive range of cardiac care services from preventive to rehabilitative. Ranked #12 as the World’s Best Cardiology Hospital by Newsweek 2025, NHCS’s clinical outcomes are consistently recognised at the international level, meeting or exceeding global standards. It is also the only facility in Singapore providing heart transplantation programme.
As an academic medical centre, NHCS is committed to training healthcare professionals and advancing cardiovascular health through cutting-edge translational research in collaboration with local and international collaborators.
For more information, please visit: www.nhcs.com.sg
Annex A
Click here to view the hi-res image.
Suggested caption:
The National Heart Centre Singapore (NHCS) inks a Memorandum of Understanding (MOU) with Mayo Clinic in a collaboration to accelerate advancement in cardiovascular care and research, and foster knowledge and innovation to transform cardiovascular care.
(L-R) Assistant Professor Ng Choon Ta, Senior Consultant, Department of Cardiology, Professor Derek Hausenloy, Director, National Heart Research Institute Singapore (NHRIS) and Professor Yeo Khung Keong, Chief Executive Officer, from NHCS, together with Professor Paul Friedman, Chair of Department of Cardiovascular Medicine, and Professor Amir Lerman, Director of Cardiovascular Research Center, from Mayo Clinic.